Insights - PDS Bio dropped 40% on the ASCO presentation after there were confusion around their confirmed/unconfirmed response rate. The company held a conference call (read transcript here) … Continue Reading
PremiumTranscripts - Webcast: https://player.vimeo.com/video/833811575?badge=0&autopause=0&player_id=0&app_id=58479%22 Participants William Doyle, Executive Chairman Ticiana Leal, Emory University Corey J Langer, University of Pennsylvania Pritesh Shah, Chief Growth Officer Ashley Cordova, Chief … Continue Reading
Read nowTranscripts - Webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=VEzQVRmI Participants Frank Bedu-Addo, Chief Executive Officer Lauren V. Wood, Chief Medical Officer Matt Hill, Chief Financial Officer Frank Bedu-Addo, Chief Executive OfficerThanks for … Continue Reading
Read nowTranscripts - Webcast: https://edge.media-server.com/mmc/p/wwuf7739 Presentation: https://ir.dayonebio.com/static-files/0caee55f-c481-48c7-9571-067e51543954 Call Participants: Joey Perrone, Senior Vice President of Finance and Investor Relations Jeremy Bender, Chief Executive Officer Samuel Blackman, Co-Founder and … Continue Reading
Read nowInsights - A few insights/notes from the ASCO abstracts that were released Thursday afternoon. ADCs Stay Winning ELEV’s ADC Validating Claudin18.2 TargetThe biggest mover from ASCO abstract release seems … Continue Reading
PremiumInsights - Biotech is bouncing back from the FTC news that raised concerns over M&A activity (read details here). Today, weight loss names are in the spotlight and … Continue Reading
Read nowInsights - The biotech rally has been put on pause on news of the FTC lawsuit to block Amgen’s (AMGN) acquisition of Horizon (HZNP). Investors are now … Continue Reading
Read now
